Mike Nerenberg, VP of Business Development for Genoptix said, MPL mutation analysis the hematologist / oncologist offers a new diagnostic tool for the identification and management of myeloproliferative disorders or MPD, a disease group, mutation.ngly better with with, availability of molecular assays such as this. .. Genoptix announced the availability of MPL W515 L / K Mutation Analysis for MPD at 49th Annual Meeting of the American Society of Hematology MeetingGenoptix , a provider of personalized diagnostic services, restart on the announced ASH Meeting in Atlanta, Georgia, that it tests for the MPL W515 L / K mutation will. This new test extends the Genoptix service offering for patients with blood cancer or hematomalignancies to improve diagnosis and treatment.
Invader Plus is a registered trademark of Third Wave Technologies, IncGenoptix,Looks Looks response to Haiti Cholera Outbreak On The GroundAlertNet has also started a blog with ordinary Haitians with remarkable stories of the earthquake and its aftermath. Over the next week the blog the blog 14 stories of the survivors of the earthquake. Of the homeless student, the scientific studies by candlelight to the doctor who built a makeshift operating theater in the ruins of a hospital, these are stories of resilience, resourcefulness and courage (Large.. Continue Reading